Analyst Reco. Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Market Closed - Nasdaq Other stock markets 04:00:04 2024-05-31 pm EDT			5-day change	1st Jan Change
7.87 ^USD	-0.13%		+9.92%	-8.59%

May. 30	BofA Securities Upgrades Alignment Healthcare to Buy From Neutral, Raises Price Target to $11 From $7.75	MT
May. 30	Baird Initiates Alignment Healthcare With Outperform Rating, $10 Price Target	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BofA Securities Upgrades Alignment Healthcare to Buy From Neutral, Raises Price Target to $11 From $7.75	May. 30	MT
Baird Initiates Alignment Healthcare With Outperform Rating, $10 Price Target	May. 30	MT
Piper Sandler Upgrades Alignment Healthcare to Overweight From Neutral	May. 08	MT
UBS Adjusts Price Target on Alignment Healthcare to $6.50 From $8.50, Maintains Neutral Rating	May. 03	MT
Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating	Apr. 23	MT
Piper Sandler Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $6 From $12	Mar. 06	MT
UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating	Feb. 28	MT
Stifel Starts Coverage on Alignment Healthcare with Buy Rating, $11 Price Target	Jan. 24	MT
Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating	Jan. 09	MT
UBS Adjusts Alignment Healthcare Price Target to $9 From $6.50, Maintains Neutral Rating	Dec. 21	MT
BofA Securities Downgrades Alignment Healthcare to Neutral From Buy	Nov. 02	MT
Raymond James Upgrades Alignment Healthcare to Strong Buy From Outperform, Adjusts Price Target to $10 From $9	23-10-16	MT
Stephens Initiates Coverage on Alignment Healthcare with Equalweight Rating, $9 Price Target	23-10-12	MT
Morgan Stanley Adjusts Alignment Healthcare's Price Target to $12 From $19, Keeps Overweight Rating	23-08-30	MT
UBS Adjusts Alignment Healthcare Price Target to $6 From $8, Maintains Neutral Rating	23-07-13	MT
JPMorgan Adjusts Price Target on Alignment Healthcare to $10 From $12, Maintains Neutral Rating	23-07-07	MT
UBS Adjusts Alignment Healthcare Price Target to $8 From $10, Maintains Neutral Rating	23-05-05	MT
Raymond James Upgrades Alignment Healthcare to Outperform From Market Perform, Price Target is $9	23-05-01	MT
Goldman Sachs Adjusts Alignment Healthcare Price Target to $12 From $14, Maintains Buy Rating	23-04-18	MT
Goldman Sachs Adjusts Price Target on Alignment Healthcare to $14 From $21, Maintains Buy Rating	23-03-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Analyst Reco.

Filters